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T cell subset modulation of immunoglobulin production in IgA
nephropathy and membranous glomerulonephritis. Monoclonal antibod-
ies directed against T cell subset antigens have been used to deplete
peripheral blood human mononuclear cells from helper (OKT4) and
suppressor/cytotoxic (OKT8') cells. Unfractionated cells and depleted
cells were assayed for their capacity to modulate pokeweed mitogen
(PWM)-driven IgG, IgA, and 1gM production by autologous B lympho-
cytes. Immunoglobulin production in the presence of these various cell
preparations paralleled the OKT4/OKT8 ratio defining the popula-
tion. Importantly, there was no clear relationship between the level of
PWM-driven Ig production by unfractionated cells and their initial
relative content in OKT4 and OKT8 cells. Patients with IgA
nephropathy and membranous glomerulonephritis showed a statistical-
ly significant increase of OKT41OKT8 ratio, suggestive of suppres-
sor T cell deficiency. There was no increase in IgA production in
patients with IgA nephropathy, even in those showing high serum IgA
level. A special feature found in patients with IgA nephropathy,
irrespective of OKT47OKT8 ratio in unfractionated cells, was a
particularly intense enhancement of IgA production after OKT8 cell
depletion in some of the patients, contrasting with a particularly low
effect of such depletion on the synthesis of all Ig classes in other
patients. In patients with membranous glomerulonephritis there was no
obvious abnormality in the modulation of Ig production by T cell
subsets, with the exception of a weak suppressor activity with respect
only to 1gM production in a significant number of patients.
Modulation par les sous-populations lymphocytaires T de Ia production
d'lmmunoglobulines dans les glomerulonéphrites a dépôts intercapillaires
d'IgA et extra-membraneuses. Des anticorps monoclonaux reconnais-
sant les antigCnes des sous-populations lymphocytaires T ont servi a
appauvrir des preparations de cellules mononuclCCes du sang circulant
en lymphocytes inducteurs (OKT4) et suppresseurs/cytotoxiques
(OKT8). C'est Ia capacitC de ces diverses preparations cellulaires, non
fractionnCes et purifiées, a moduler La production d'IgG, d'IgA, et
d'IgM par les cellules B autologues en réponse au pokeweed-mitogene
(PWM), qui a etC Ctudiée, La production d'immunoglobulines en
presence de ces diverses preparations cellulaires est parallele au
rapport OKT4/OKT8 dCfinissant Ia population cellulaire en cause. Ii
faut noter l'absence de correlation nette entre Ic taux d'immunoglobu-
lines produites en rCponse au PWM par les cellules non fractionnées et
leur contenu initial en lymphocytes OKT4 et OKT8. Dans les
glomerulonéphrites a depots intercapillaires d'IgA et extra-membran-
euses, le rapport OKT4/OKT8 est ClevC de facon statistiquement
significative, cc qui suggere un deficit numérique des cellules T
suppressives, La production d'IgA n'est pas accrue dans les gloméru-
lonéphrites a depots d'IgA, mCme chez les malades ayant un taux
serique d'IgA élevé. De facon propre aux glomerulonephrites a depots
d'IgA, independamment du rapport QKT4/OKT8 initial des cellules
non fractionnCes, l'appauvrissement en lymphocytes OKT8 est suivi
chez une fraction de malades par une exacerbation particuliérement
intense de la production d'IgA, tandis que chez les autres, cette
purification n'a qu'un trCs faible effet sur la synthése des trois classes
d'immunoglobulines. Dans les glomCrulonéphrites extramembraneuses,
on ne constate pas d'anomalie grossiCre de Ia modulation par les sous-
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populations T de la production d'immunoglobulines hormis Ia faible
activité suppressive, a l'égard de Ia production d'IgM uniquement,
présente chez une partie des patients.
In vitro activation of peripheral blood mononuclear cells
(PBM) with pokeweed mitogen (PWM) provides an interesting
probe to evaluate the function of the regulatory cells involved in
the generation of immunoglobulin (Ig) production. PWM-driven
differentiation of B cells has been shown to depend on mono-
cytes [1], T cells [2], or their soluble products [3], and is
submitted to the oppposing effect of helper and suppressor
influences [4, 5]. Regulatory T cells have been recently defined
in humans by use of monoclonal antibodies, namely OKT4,
which binds to helper T cells, and OKT8 which recognizes
suppressor/cytotoxic T cells [6].
We have studied PWM-driven Ig production by PBM and its
modulation by T cell subsets in normal individuals and patients
with two types of idiopathic glomerulonephritis (GN) where the
OKT4/OKT8 ratio had been shown to be increased: IgA
nephropathy and membranous glomerulonephritis [7]. IgA
nephropathy (Berger disease) is defined by mesangial deposits
of IgA associated in 30 to 50% of patients with increased serum
IgA level and in 60% of patients with the HLA-DR4 antigen [8,
9]. Membranous GN (MGN) is defined by the presence of
granular subepithelial deposits of IgG with or without 1gM or
complement along the glomerular basement membrane. It has
recently been reported to be associated with a high frequency of
the HLA-DR3 antigen [10J and with depressed in vitro antibody
production. It is interesting that both antigens (DR4 and DR3)
show increased frequency in a variety of autoimmune disorders
where evidence for operationally deficient suppressor T cells
exists. Finally, the question addressed by this work was to test
whether the numerical desequilibrium between the OKT4 and
OKT8 subsets was reflected in an operational dysfunction, as
assessed by the effect on PWM-driven Ig synthesis.
Methods
Patients. Eighteen patients with IgA nephropathy (nine males
and nine females), aged 19 to 59 (mean, 32 years) and eight
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Table 1. Clinical and biological data of patients with glomerulonephritis at the time of the current study
Apparent
Patient Age duration of
no. years Sex disease Renal biopsy
Creatininemia
p.moleslliter
Proteinemia
g124 hr
Microscopic
hematuria Hypertension
Serum
IgG
Ig, g/
IgA
litera
1gM
IgA nephropathy
1 23 F 5 years MES-PGN, cresc. 70 1.2 + — 12.2 2.5 3.25
2 43 F 10 years MES-PGN 80 1.6 + — 8.77 3.89 0.87
3 32 M 3 years MES-IgA 100 0.75 +(int) — 12.57 4.82 1.83
4 22 M 5 years MES-PGN, cresc. 110 6.2 + — 4.7 1.95 0.57
5 25 M 2 years MES-PGN, cresc. 90 0.85 + 9.4 4.43 1.2
6 33 F 3 years MES-IgA, cresc. 80 0.2 + — 13.2 2.2 1.7
7 27 M 10 years MES-IgA, cresc. 130 4.6 + + 7.2 2.3 0.6
8 27 M 5 years MES-PGN, cresc. 90 1.3 + — ND ND ND
9 59 M 6 years MES-IgA 230 l, + 14 2.92 1.8
10 40 F 22 years MES-PGN 70 — — 12.7 2.48 1.5
11 32 M 10 years MES-PGN, cresc. 160 3 + (M) — 5.7 2.3 1.09
12 32 F 10 years MES-PGN 140 +' +(int) + 11.5 3.7 1.3
13 38 M 8 years MES-IgA, cresc. 120 0.7 + + 8.62 3.67 0.76
14 32 F 8 years MES-IgA 80 1.5 — — 9.93 2.58 2.18
15 19 F 5 years MES-PGN 80 +(int) +(int)(M) — 12.2 4.40 1.66
16 31 F 14 years MES-IgA 70 0.75 +(int) — 10.56 2.45 1.87
17 21 M 5 months MES-PGN, cresc. 100 0.7 + — 13.2 4.76 1.39
18 39 F 13 years MES-IgA 110 0.92 9.4 3.1 1.3
Membranous glomerulonephritis
1 43 F 4 years MGN 11° 80 0.5 — — ND ND ND
2 54 M IOyears MGNI 110 — — — ND ND ND
3 20 F 6 years MON 90 9 (NS) + — 2.57 1.07 1.36
4 18 M 10 years MGN II 90 13.5 (NS) + — 2.83 2.55 1.22
5 22 M 1 year MGN II 255 10 to 20 (NS) + — 0.8 0.8 1.3
6 19 M 1 year MON I 90 8.6 (NS) — — 1.25 1.26 2.2
7 31 F 9 years MON II 60 1.9 — — 5.6 3 1.1
8 25 F 6 months MGN lI-Ill 80 0.6 + — 10.16 1.8 1.84
Abbreviations and symbols: MES-PON, mesangial proliferative UN; MES IgA, mesangial deposits of IgA without endocapillary proliferation;
cresc., segmental epithelial cellular crescents; int, intermittent; ND, not done; M, bouts of gross hematuria; NS, nephrotic syndrome, defined by
proteinuria > 3 g/24 hr, serum protein < 60 g/liter, and serum albumin < 30 g/liter; +, present; —, absent.
a Serum Ig concentrations were determined by nephelometry at the time of the current study, or in some cases (italics) at the time of the
diagnosis, no more than 2 years prior to this study.
Semi-quantitative dosage was administered.
MGN is classified in histologic stages according to Bariéty et al [11].
patients with membranous glomerulonephritis (four males and
four females), aged 18 to 54 (mean, 29 years), were studied in
functional and phenotypic assays. The diagnosis was assessed
by renal biopsy in each individual. In no instance was clinical or
biological evidence for a general disease (for example, systemic
lupus) or extrarenal pathology (for example, hepatic cirrhosis),
or an etiologic agent found. None of these patients received, at
the time of the study, any treatment known to alter the immune
system (for example, steroids). More detailed clinical and
biological data are presented in Table I. In addition a larger
series of patients was analyzed for peripheral T cell subset
distribution. This series includes the patients described above,
the patients studied in the previous report [7], and nine addi-
tional patients (six with IgA nephropathy and three with mem-
branous GN) where functional studies could not be performed.
Controls. Thirteen normal volunteer blood donors, age- and
sex-matched with renal patients were used as control subjects.
Antibodies. Monoclonal mouse IgG antibodies (OKT4,
OKT8) were kindly donated by G. Goldstein (Ortho Pharma-
ceutical Corp., Raritan, New Jersey). Goat anti-mouse serum
(GAM) used for cell separation was obtained from Miles
Laboratories (Elkhart, Indiana). It was subsequently absorbed
on human Ig and further purified by affinity chromatography on
a mouse IgG column. Goat anti-mouse IgG serum used for
immunofluorescence (IF) analysis was obtained from Nordic
Immunological Laboratories (Tilburg, The Netherlands).
Lymphocyte isolation and purfi cation. PBM were obtained
from heparinized venous blood by density gradient centrifuga-
tion (Telebrix®, Paris, France). After two washings in Hanks
balanced saline solution (Laboratoires Eurobio, Paris, France),
cells from the interface layer were submitted to cellular separa-
tion. Ten million PBM were incubated in I ml RPM! 1640
(Gibco, Grand Island Biological Co., Grand Island, New York)
for 30 mm at 4°C with the monoclonal OKT4 or OKT8 (0.5 to I
ig monoclonal in 5 1a1 per io PBM). They were then layered on
plain Petri dishes (5.5 cm diameter, Labo Express Service,
Viry-Chatillon, France) that had been pre-incubated overnight
at 4°C with 150 j.tg purified GAM in 5 ml phosphate-buffered
saline (PBS) without Ca+ + and Mg+ + (Gibco). OKT-incubat-
ed cells were allowed to adhere to GAM-coated dishes for 60
mm at 4°C. Nonadherent cells were decanted by several gentle
washes in cold PBS. Such negative selection provided purified
cell-subsets, called OKT4 (when depleted of OKT4 cells)
and 0KT8 (when depleted of OKT8 cells); the purified cell-
subsets contained more than 95% viable cells as judged by
Trypan-blue dying.
Selective cellular depletion proved to be optimal when 5 x
106 PBM were layered on GAM-coated Petri-dishes and only a
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limited number of cautious washings were performed to recover
nonadherent cells. Contamination of depleted subsets by irrele-
vant cells was usually less than 1% for OKT8 cells and 3% for
0KT4 cells, as assessed by indirect immunofluorescence. It
should be noted, however, that the cell yield was relatively
poor. To recover enough cells to perform functional experi-
ments, l0 PBM were used to undergo cell depletion which lead
to infra-optimal contamination by a number of irrelevant cells,
which was less than 5% for 0KT8 cells and less than 10% for
0KT4 cells. It is important to note, however, that such
contamination may not have had a major influence in the
culture since immunofluorescence analysis of the lymphocyte
suspension after a 2-day culture showed that the percentage of
irrelevant cells was then always less than 1%, whatever the
initial level of purification (judged by immunofluorescence
performed prior to culture initiation, immediately after the cells
were recovered from Petri dishes).
Immunofluorescence analysis of lymphocyte suspensions.
Indirect IF was performed on all samples of unfractionated
PBM and in some instances on purified preparations using
mouse monoclonal antibodies specific for all circulating T cells
OKT3 (Ortho Pharmaceutical Corporation) or T cell subsets
(OKT4 and OKT8) [61. Briefly, 0.5 to 1 x 106 cells were first
incubated in 50 p1 with 5 p1 (0.5 to 1 g) of the monoclonal for
30 mm at 4°C. After washing in cold medium (Hanks balanced
saline solution, supplemented with 5% fetal calf serum and
0.2% sodium azide), the pellet was incubated with 5 p1 of an
appropriate dilution of fluorescein-conjugated GAM (Nordic) at
4°C for 30 mm. After washing in the same cold medium, a drop
of the lymphocyte suspension was examined with a microscope
(Leitz Orthoplan) and approximately 200 PBM were counted
per slide. T cell subsets were expressed as a percentage of the
total PBM. Monocytes and B cells were identified by means of a
double immunofluorescence assay using the OKM1 monoclonal
antibody (Ortho Pharmaceutical Corporation) [12]. The cells
were first incubated with OKM1 (mouse IgG 2b), washed, and
then treated with a mixture of rhodamine-conjugated goat anti-
mouse IgG2b antiserum and fluorescein conjugated Fab goat
anti-human Fab antiserum (Nordic).
Pokeweed mitogen cellular activation. Cell cultures were
performed in round-bottomed microwell plates (Nunclon-Delta,
Nunc, Denmark). Culture medium was RPM! 1640 supple-
mented with 10% (v/v) heat-inactivated fetal calf serum
(FCS, Gibco), 2 mrvi glutamine (Gibco), 1% (v/v) antibiotic
mixture containing 5000 U/ml penicillin and 5000 sg/ml strepto-
mycin (Gibco) and 10 ig/ml gentamycin (Unilabo, Levallois,
France). The cell suspension was adjusted to a concentration of
0.5 x 106 viable cells/ml and distributed by 0.2 ml samples (l0
cells/well). The total number of cells per well was kept constant
when the proportion of each cellular subset varied. Each
experimental condition variable (proportion of regulatory cell
subsets) was tested in several wells. PWM (Gibco) was added at
1/100 final concentration in 10 p1 of medium in half of these
wells. Cultures were incubated for 7 days in a humid 5% CO2
containing atmosphere at 37°C. On day 7 of the culture, plates
were centrifuged; supernatants of each well from corresponding
cell subsets were pooled and stored at —18°C until the Ig assay.
Assay for Ig production in culture supernatants. The
amounts of IgG, IgA, and 1gM produced by lymphocytes
cultured in the presence or absence of PWM were determined
using an automated laser nephelometer (Hyland, Division Tra-
venol Laboratories Lessines, Belgium). Appropriate aliquots of
supernatants (25 to 150 p1) were mixed with specific anti-human
!gG, IgA, or 1gM antibodies (Hyland) in 1 ml diluent medium
(Hyland). After a 3-hr incubation, immune precipitates were
dosed by laser spectrometry. Results were expressed for each
!g class in nanograms per milliliter of culture medium by
comparison to a reference curve obtained with purified human
!g (Miles Laboratories, Elkhart, Indiana) and performed with
each dosage procedure. Reproducibility of the method was
verified in within-run and day-to-day tests of the same speci-
men. Accuracy was assessed by the similar levels of IgG
obtained from this test and a solid phase radio-immunoassay.
Inferior limit of sensitivity of the test was of the order of 100 ng
IgIml. Culture medium alone (containing 10% FCS) did not
produce any significant background. It was verified that pure B
cells obtained by triple panning with OKT4, OKT8, and OKM1
monoclonals did not produce appreciable amounts of Ig after
PWM addition. This observation excludes significant contribu-
tion in our culture system of spontaneous Ig release from the B
cells.
Statistical analysis. Mean comparisons were done by use of
Student's t test. Ig production levels were compared in distribu-
tion-free tests (Mann and Whitney).
Results
T cell regulation of Ig production in normal control subjects
(Table 2, Figs. 1, 2, and 3)
The level of production of each Ig class by unfractionated
PBM in response to PWM was quite variable from one donor to
another, without direct correlation between Ig classes: Thus,
donors numbered 9 to 13 were good IgA producers but did not
synthetize much IgG or 1gM. No correlation was found between
PWM-induced !g production by unfractionated PBM and their
initial OKT4/OKT8 ratio, neither with their content in sur-
face immunoglobulin (SIg) cells. A significant Ig production
was noted in cultures of unfractionated PBM performed in the
absence of PWM.
The 0KT4 subsets generally exhibited a lower Ig produc-
tion than unfractionated cells. 0KT4 cells produced the same
amount of Ig in the presence or absence of PWM, suggesting B
cell activation by endogeneous polyclonal activators or fetal
calf serum present in the culture medium. PWM-driven Ig
production was generally higher in 0KT8 cells than in unfrac-
tionated PBM.
A couple of experimental points in each cell subset displays
paradoxical response. This could be due to biological variability
or perhaps to some form of cell activation inherent to the
separation procedure employed.
To test the hypothesis of a nonspecific activation of the
purified cell subsets through the passage on Petri dishes, normal
PBM, not preincubated with OKT, with either freshly cultured,
or layered on GAM-coated Petri dishes and further processed
as in the separation experiments: Ig production was similar in
both instances (for example, in one representative experiment,
PWM-driven Ig production is respectively in absence and after
GAM-coated dish passage: IgG 1142 ng/ml vs. 1224 ng/ml, IgA
1708 ng/ml vs. 1870 ng/ml, and 1gM 186 vs. 323 ng/ml).
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Table 2. In vitro IgG, IgA, and 1gM production in normal control subjects by unfractionated cells, 0KT4, and 0KT8 subsetsa
Indi-
vidual OKT4/
Unfractionated cells 0KT4 subset
IgG
0KT8 subset
igGIgG IgA 1gM
no. OKT8' SIg (%)a OKT4IB'1 Sa NS S NS S NS S NS S NS
1 2.93 10.8 6.2 4527 1444 4412 1650 3949 831 673 490 5814 286
2 2.05 11.6 3.8 3584 171 3818 849 2410 780 1071 931 5329 673
3 1.74 9.9 5.2 2958 1009 1706 762 1605 471 1420 1077 5391 1941
4 1.36 15.5 3.2 1348 552 2328 1020 1117 375 684 613 2904 485
5 1.48 10.1 4.1 4148 2569 2361 892 1382 444 — — — —
6 0.9 — — 4300 3314 — — — — 1163 880 6976 887
7 1.41 8.7 5.9 642 757 504 634 295 257 1666 1475 6269 1158
8 1.25 7.6 6.4 697 592 605 459 195 272 4732 5295 12100 3472
9 0.87 9.1 3.4 410 <100 1876 691 729 158 286 318 4665 552
10 1.38 15.7 2.6 630 <100 1836 739 301 152 855 544 4279 817
11 1.25 17.3 2 349 <100 1990 167 372 138 470 380 13683 1192
12 2.72 7.1 8 696 128 2466 896 801 288 215 446 340 250
13 2.04 — — 769 100 1379 786 462 250 249 234 290 <100
a Ig production is expressed as nanograms per milliliter of culture supernatant. Culture medium alone or purified B cells alone gave results less
than 100 ng/ml. Variations in IgA and 1gM production by OKT-depleted subsets are not represented; they were very generally parallel to IgG
variations (compare with Figs. 1, 2, and 3).
b The values represent the ratio of the OKT4 and OKT8 cells (expressed as percentage of total PBM) in the initial unfractionated population.
The values represent the percentage (of total PBM) of B cells (detected by their surface-bound Ig) in the initial unfractionated population.
d The values represent the ratio of OKT4 and SIg cells (expressed as a percentage of total PBM) in the initial unfractionated population; at
variance with others [13, 14, 201, we did not find a clear influence of the OKT4+IB ratio on the helper function of OKT4+ lymphocytes, with no
greater Ig production by unfractionated cells nor greater susceptibility of Ig production to OKT8+ cell depletion at low OKT4+IB ratios.
The values are from PMW-stimulated cultures.
The values represent cultures performed without PWM.
Fig. 1. In vitro IgG production by PWM-stimulated lymphocytes. This
figure depicts the variations of PWM-induced IgG synthesis (nanograms
per milliter of culture supernatant) studied at three different OK-
T4/OKT8 ratios as found in unfractionated PBM (UF), 0KT4 and
0KT8 subsets, in normal individuals (left), IgA nephropathy (center),
and membranous glomerulonephritis (MGN) (right). Paradoxical re-
sponses of 0KT4 subsets of donors 7 and 8 (see Results) are not
connected by bars with their respective UF lymphocytes. Note the
logarithmic scale.
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Fig. 2. PWM-induced IgA in vitro production.
subjects. The level of spontaneous and PWM-driven Ig produc-
tion was not correlated to the initial OKT4/OKT8 ratio which
was found to be abnormally high in eight out of the 18 patients
(44%) studied. Interestingly, PWM-induced increase in IgA (but
not IgG or 1gM) production in unfractionated PBM which
tended to be smaller in IgA nephropathy than in control
subjects or membranous glomerulonephritis patients (Fig. 4)
(not statistically significant). Overall IgA production by PWM-
I I I I I I I I I
Immuno globulin production in IgA nephropathy (Table 3)
PWM-stimulated unfractionated PBM showed the same het-
erogeneity in the production of each Ig class as in control
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stimulated cells was less decreased by OKT4 cell depletion in
patients with IgA nephropathy than in control subjects or
patients with membranous nephropathy (Fig. 2). 0KT8 cells
did not produce exaggerated amounts of IgA nor of other Ig
class after PWM stimulation when compared to control sub-
jects. However, as illustrated in Figure 2, OKT8 cell depletion
revealed a dual behavior in IgA production; this production was
enhanced sharply in some patients, while in others it was not
appreciably increased or even was markedly decreased. This
latter trend, suggestive of globally deficient suppressor T cells,
was also observed in some patients for IgG and 1gM, but the
dual behavior was only clear-cut for IgA secretion. This feature
is particularly apparent on Figure 5 where ratios of PWM-
induced IgA secretion by 0KT8 and 0KT4 subsets are
plotted together for IgA nephropathy, control subjects, and
MGN. These data may indicate that IgA nephropathy is immu-
nologically heterogeneous. One should note, however, that the
duality in the modulation of IgA production is not related to
individual OKT4/OKT8 ratios (Table 3 and Fig. 6), nor to
any clinical or biological data.
Immuno globulin production in membranous
glomerulonephritis (Table 4)
The level of Ig production was not correlated with the
OKT4/OKT8 ratio in resting unfractionated cells, which was
found to be elevated in four out of seven patients (57%). As in
control subjects, variations in IgG and IgA production paral-
leled variations in helper/suppressor T cell ratios after OKT4
and OKT8 cell depletion. No correlation was found between
the intensity of these variations in Ig production and the
OKT4/OKT8 ratio in unfractionated cells. Interestingly, with
respect only to 1gM (Fig. 3), five out of eight patients (62%)
exhibited a decrease in Ig synthesis after OKT8 cell depletion,
suggesting a deficient T cell suppressor activity, which, howev-
er, was only poorly correlated with numerical distribution of the
T cell subsets in unfractionated PBM.
Discussion
Anti-T cell monoclonal antibodies have been used to physi-
cally separate the T cell subsets which they recognize by
panning on inert supports [15—18]. The data reported in this
article confirm previous findings showing that in vitro PWM-
driven B cell differentiation into IgG, IgA, and 1gM-secreting
plasmoyctes depends both on helper T cells (OKT4) and
suppressor T cells (OKT8). Although some helper or suppres-
sor [1, 19] functions have been attributed to monocytes, it is
unlikely that they contributed significantly in our system, since
monocytes were present in similar proportions in all experi-
ments. In practical terms, Ig production was evaluated in three
experimental conditions defined by a 1/initial OKT4/OKT8
ratio present in resting unfractional cells (normal range, 1 to 2);
low OKT4/OKT8 ratio after OKT4 cell depletion (ranging
from 0.01 to 0.2) and a 3/high OKT4/OKT8 ratio after
OKT8 cell depletion (ranging from 10 to 100).
It is apparent that even if in most subjects (normal control
subjects and patients) Ig production showed a parallel increase
to the OKT4/OKT8 ratio (Figs. 1, 2, and 3), no clear
correlation was found between absolute levels of Ig production
or degree of changes in Ig production after T cell subset
removal and OKT4/OKT8 ratio. The absence of strict corre-
lation between function (modulation of Ig production) and
numerical level (OKT4/OKT8 ratio) of T cell subsets is
consistent with the absence of unique cellular function in the
subsets defined by these monoclonals: OKT8 lymphocytes
comprise both suppressor and cytotoxic cells 16]; the heteroge-
neity of OKT4 subset is under dissection [20—221.
The patients with IgA nephropathy and MGN examined in
this study are part of a larger series of patients that have been
investigated for OKT-defined blood T cell subsets. As seen in
Figure 6, this larger series study agrees with a previous report
from our own series [7]; it shows an abnormally elevated
OKT4/OKT8 ratio in IgA nephropathy and MGN, predomi-
nantly due to diminished OKT8 subset. Other records confirm
the relative decrease of the OKT8 peripheral subset in MGN
[23, 24]; in IgA nephropathy, no anomaly was found by Cagnoli
et al [24]. The distribution of peripheral T cell subsets was
studied in other varieties of ON. No clear abnormality was
found in minimal change ON nor in membranoproliferative ON
[7, 24]. It has been suggested that in systemic lupus erythemato-
sus with severe active renal involvement, the helper/suppressor
ratio is often low [25].
Numerous immunological abnormalities have been described
in idiopathic IgA nephropathy including high serum levels of
IgA [26, 27] and particularly polymeric IgA [28, 29]; IgA
containing circulating immune complexes [26, 27, 29, 30],
sometimes found only intermittently in association with epi-
sodes of macroscopic hematuria [26]; increase of IgA-bearing
blood lymphocytes [31, 32], eventually familial [33]; presence of
IgA-producing lymphoid cells in renal interstitium [27]; and
decreased IgA-specific suppressor T cell activity [34].
This study did not reveal exaggerated spontaneous or PWM-
driven in vitro Ig production (particularly of the IgA class) even
in the nine patients (numbered 2, 3, 5, 10, 12, 13, 15, 17, 18) who
exhibited elevated serum IgA levels. These results conflict with
those of Egido et al [35] who showed that in vitro IgA synthesis
by PBM was specifically exaggerated in patients with IgA
nephropathy.
A more striking feature of patients with IgA nephropathy was
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Fig. 3. PWM-induced 1gM in vitro production.
MGN
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Table 3. In vitro IgA, IgG, and 1gM synthesis by unfractionated cells, and variations of IgA production by OKT-depleted subsets from patients
with IgA glomerulonephritis
Patient
no. OKT4/OKT8
Unfractionated cells OKT
S
4 subset
IgA
NS
0KT8 subset
IgA
S NS
IgA
S NS S
lgG
NS
1gM
S NS
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
3.57
1.7
1.45
1.75
1.14
3.61
2.34
1.21
2.78
1.62
1.09
2.19
1.39
1.79
1.46
1.07
1.05
1.61
4610
528
543
469
733
1209
1285
1582
2233
2629
752
799
1717
1680
1771
2783
4976
3358
1569
301
400
495
626
415
438
600
1071
934
500
924
626
816
681
1782
2073
1538
12242
3679
1582
541
1961
4052
<100
<100
1572
1422
790
2345
1065
974
1112
3452
7740
9633
2990
2731
1114
230
1785
330
<100
397
973
388
367
1167
445
489
521
2788
3775
920
5080
274
510
231
626
1679
617
732
831
813
1240
3666
186
178
252
722
1793
2036
1584
187
242
148
437
185
218
1188
419
324
424
550
<100
106
125
629
1246
844
3600
399
532
431
1582
491
721
1003
1186
1332
1075
854
723
737
831
1373
—
—
1064
446
—
466
1618
870
844
512
1159
1652
823
317
690
902
704
991
—
—
1899
517
573
1600
4611
7025
10521
9888
2789
2824
10677
9316
1798
2399
6102
2752
—
—
1304
360
418
404
1448
474
735
656
651
2473
3519
618
666
815
687
750
—
—
Legends and abbreviations are the same as those used in Table 2.
a Variations of IgG and 1gM production by OKT-depleted subsets are not represented (compare with Figs. 1 and 3).
.
.
Controls IgA nephropathy MGN
Fig. 4. Enhancement of IgA synthesis induced by PWM stimulation.
This figure represents the ratio of IgA production by cultures of
unfractionated PBM with and without PWM. The tendency to decrease
in vitro IgA production by patients with IgA nephropathy is not
statistically significant (distribution-free test of Mann and Whitney).
Increment of PWM-induced IgA synthesis by unfractionated PBM is
not statistically different (Mann and Whitney's test) from increment of
IgG or 1gM synthesis by these cells, as well in patients with IgA
nephropathy as in control subjects or patients with MGN (data not
illustrated).
their dual behavior in IgA synthesis by 0KT8 purified cells.
The absence of enhancement of IgA production of OKT8 cell
depletion observed in some patients could suggest a deficient
suppressor T cell function favoring an increased production.
This observation agrees with that of Egido et al [36] showing
deficient suppressor T cell function in 40% of patients with IgA
S
.
I
.
Controls gA nephropathy MGN
Fig. 5. Regulatory function of T cell subsets on PWM driven IgA
synthesis. The regulatory activity of T cell subsets is expressed by the
ratio of PWM-induced IgA synthesis by 0KT8 versus 0KT4 sub-
sets. This figure illustrates the immunological heterogeneity of patients
with IgA nephropathy, in terms of dual behavior in modulation of IgA
synthesis by T cell subsets.
15
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S
15
.
.
S
10 . S.
• .
5 5
S
S
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nephropathy. However, at variance with the report by Sakai,
Nomoto, and Arimori [34], the anomaly of suppressor T cell
activity was not IgA-specific.
The exaggerated increase in IgA production of 0KT8 cells
noted in some patients is more difficult to relate to the concept
of deficient suppressor T cell activity. The role of isotype-
specific helper T cells well established in humans as in the
mouse [37] must be recalled. In IgA nephropathy, an excess of
IgA-specific helper T cells has recently been reported [38].
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Table 4. In vitro IgG, IgA, and 1gM production by unfractionated PBM and modulation of 1gM production by OKT-depleted subsets of patients
with MONa
Patient
no. OKT4/OKT8
Unfractionated cells OKT
S
4 subset
1gM
NS
0KT8 subset
1gM
S NS
IgG
S NS S
IgA
NS
1gM
S NS
1
2
3
4
5
6
7
8
1.91
1.27
2.37
1.93
1.36
1.25
2.33
—
2953
2209
4382
3047
4217
1660
6201
811
790
747
643
925
232
124
2155
414
1726
1050
4440
2170
4548
3333
6697
1142
766
613
408
533
1488
2347
459
1211
816
754
3777
1778
7913
3602
4296
232
605
280
237
289
1495
671
361
256
545
1588
969
329
943
736
388
273
493
622
507
297
345
—
373
—
941
1585
2653
955
2962
2033
2326
592
401
226
269
230
1594
359
1050
—
Legends and abbreviations are the same as those used in Table 2.
Variations of IgG and IgA production by OKT-depleted subsets are not represented (compare with Figs. I and 2).
70% 401. A number of immunological abnormalities have been
reported in patients with membranous GN: In vitro decreased
60 synthesis of IgG and 1gM by PBM, a phenomenon attributed to
suppressor monocytes [41]; presence of a factor in the serum of
50 nephrotic patients depressing normal lymphocyte transforma-
tion induced by concanavalin A [42]; deficient macrophage-
40 migration inhibitory factor production by T cells in response to
a variety of antigens [43]. At variance with these findings, our
data do not bring any evidence for gross abnormalities in T cell
30 function and regulation of Ig secretion in patients with MGN.
At most, production of IgG, IgA, and 1gM tended to be greater
20 than that of normal PBM. The level of in vitro Ig production by
individual patients was irrelevant to the histological picture as
10 to any clinical feature. The most apparent feature was an
insensitivity to OKT8 cell depletion, suggestive of a deficit in
o suppressor T cell activity, regarding 1gM production in 62% of
our patients, irrespective of the OKT4/OKT8 ratio in their
unfractionated resting PBM. However, a bias could have been
introduced in our results: As shown in Figure 6, patients with
MGN in this study are not evenly distributed with regard to the
arithmetic mean of our larger series of patients, as is the case
for patients with IgA nephropathy, or controls. Instead, they
segregate at a relatively low-grade OKT4/OKT8 ratio and
high-grade percentage of OKT8 lymphocytes.
In conclusion, this article describes a new functional assay
system of lymphocyte cooperation, allowing a quantitative
evaluation of functional T cell subsets in human blood. It
generally confirms the immunological significance of OKT4
and OKT8 cells. When applied to two types of GN where the
OKT4/OKT8 ratio has been found abnormally high in a
significant percentage of patients, the findings indicate that no
clear-cut functional correlation could be noted. However, in
IgA nephropathy, a subpopulation of patients displayed a weak,
not Ig-class restricted, suppressor activity. In MGN a signifi-
cant fraction of the patients showed a deficit of the suppressor
activity with respect to 1gM synthesis only.
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Fig. 6. Distribution of regulatory T cell subsets in normal individuals,
patients with IgA nephropathy and patients with MGN. OKT4 and
OKT8 cell levels are expressed as percentage of total PBM; OK-
T4/OKT8 ratio is the quotient of these values in each individual.
Closed circles represent the experimental points of this study. Their
distribution is compared to the mean (± 5EM) of our larger series, which
is illustrated as a histogram. Mean comparisons were made by use of
Student's t test:
Normal individuals (N = 30) OKT3 = 69.5 2.1%
OKT4 = 47.3 1.8%
OKT8 = 30 1.5%
OKT4/OKT8 = 1.67 0.09
IgA Nephropathy (N = 33) OKT3 = 68.6 1.8% (statistically not
different from controls)
OKT4 = 47.3 1.7% (statistically not
different from controls)
OKT8 = 25.2 l.4% (P < 0.01)
OKT47OKT8 = 2.09 0.17 (P < 0.03)
MGN (N = 21) OKT3 = 65.9 3.0% (statistically not different from
controls)
OKT4 = 45.3 2.1% (statistically not different from
controls)
OKT8 = 22.7 1.9% (P < 0.01)
OKT4/OKT8 = 2.25 0.18 (P < 0.001)
Taken together these results suggest that IgA nephropathy is
not a uniform entity. This view is further supported by contra-
dictory claims regarding prevalence of mesangial deposition of
IgA 1 (serum) and IgA 2 (secretory) subclasses of IgA [28, 39,
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